Peter L. Salgo, MD: Individualizing care, individualizing any patient’s regimen, starts with what? How do you identify who needs this? How do you identify how urgent this is? Is it the HIV RNA level, ...

BUENOS AIRES, ARGENTINA, July 10th, 2001 – A study presented today at the 1st International AIDS Society Conference on HIV Pathogenesis and Treatment shows that Virco’s resistance tests can predict ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — The Infectious Diseases Society of America Foundation named Edsel Salvana, MD, DTM&H, FDCP, FIDSA, its ...

HIV drug resistance (HIVDR) can emerge with use of antiretroviral (ARV) drugs for HIV treatment and prevention. The increasing prevalence of drug-resistant HIV strains poses a serious threat to the ...

Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. Researchers ...

Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than adults ...

Singapore-based Vela Diagnostics Holding Pte. Ltd. has received U.S. FDA authorization via the de novo approval pathway for an in vitro diagnostic test to detect HIV-1 genomic drug resistance ...

Out of an estimated 104,000 people offered HIV preexposure prophylaxis (PrEP) to protect themselves from HIV, just 14 people acquired a strain of HIV resistant only to the two drugs used in the HIV ...

—Transmitted drug resistance from patients on suboptimal ART increases the risk of treatment failure and disease transmission, but data are limited. These investigators assessed drug resistance ...